Home › Companies › ALNYLAM PHARMACEUTICALS INC. › 2024-2025
Compiled from SEC Form N-PX filings and ALNYLAM PHARMACEUTICALS INC.’s Form 8-K, filed 2025-05-13 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Explore ALNYLAM PHARMACEUTICALS INC. in the interactive database Compare manager voting policies
These tallies are ALNYLAM PHARMACEUTICALS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-05-13 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Carolyn R. Bertozzi, Ph.D. | 108,200,098 | 10,440,708 | 24,081 | -- | 4,826,451 | Majority: yes |
| Elect Director: Margaret A. Hamburg, M.D. | 108,041,420 | 10,601,230 | 22,237 | -- | 4,826,451 | Majority: yes |
| Elect Director: Colleen F. Reitan | 111,919,864 | 6,734,585 | 10,438 | -- | 4,826,451 | Majority: yes |
| Elect Director: Amy W. Schulman | 103,753,055 | 14,370,696 | 541,136 | -- | 4,826,451 | Majority: yes |
| The terms of office of the following directors continued after the Annual Meeting: Dennis A. Ausiello, M.D. | 111,515,553 | 7,120,857 | 28,477 | -- | 4,826,451 | Majority: yes |
| Proposal 3: The Company's stockholders approved the Company's Second Amended and Restated 2018 Stock Incentive Plan. | 114,044,496 | 4,590,661 | 29,730 | -- | 4,826,451 | Majority: yes |
| Proposal 4: The Company's stockholders approved, in a non-binding advisory vote, the compensation of the Company's named executive officers. | 111,725,907 | 6,909,706 | 29,274 | -- | 4,826,451 | Majority: yes |
| Proposal 5: The Company's stockholders ratified the appointment by the Company's Board of Directors of PricewaterhouseCoopers LLP as the Company's independent auditors for the fiscal year ending December 31, 2025. | 117,032,947 | 6,405,215 | 53,176 | -- | 0 | Majority: yes |
Source: ALNYLAM PHARMACEUTICALS INC., Form 8-K, filed with the SEC on 2025-05-13 — read the filing on EDGAR.
Each item below shows how the 586 asset managers that disclosed a ALNYLAM PHARMACEUTICALS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of ALNYLAM PHARMACEUTICALS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Meeting held 2025-05-08.
Combines 24 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
ALNYLAM PHARMACEUTICALS INC.’s own tally for this item (“Proposal 4: The Company's stockholders approved, in a non-binding advisory vote, the compensation of the Company's named executive officers.”): 111,725,907 for, 6,909,706 against, per its Form 8-K filed 2025-05-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 130,311,000 outstanding shares: 86% for, 5% against (91% of the company cast a for/against vote).
The 582 asset managers below cast 96% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the company's reported shares outstanding.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 34,588,987 | 0 | 0 | 0 | For |
| Fidelity | 27,323,740 | 0 | 0 | 0 | For |
| Vanguard | 16,325,264 | 1 | 0 | 0 | For |
| T. Rowe Price | 12,860,909 | 359,344 | 0 | 0 | For |
| BlackRock | 8,536,300 | 0 | 0 | 0 | For |
| Capital Research Global Investors | 7,118,387 | 0 | 0 | 0 | For |
| Dodge & Cox | 5,730,974 | 0 | 0 | 0 | For |
| State Street | 3,586,063 | 0 | 0 | 0 | For |
| JPMorgan | 3,258,456 | 0 | 0 | 0 | For |
| Wellington | 2,943,019 | 0 | 0 | 0 | For |
| AMCAP FUND | 2,401,920 | 0 | 0 | 0 | For |
| American Century | 0 | 2,391,376 | 0 | 0 | Against |
| GEODE CAPITAL MANAGEMENT, LLC | 2,282,770 | 0 | 0 | 0 | For |
| Winslow Capital Management, LLC | 2,140,323 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 1,607,880 | 0 | 0 | 0 | For |
| BAILLIE GIFFORD & CO LTD | 1,454,257 | 0 | 0 | 0 | For |
| Orbis Allan Gray Ltd | 1,319,195 | 0 | 0 | 0 | For |
| Charles Schwab | 1,136,283 | 0 | 0 | 0 | For |
| BAILLIE GIFFORD OVERSEAS LTD | 1,060,161 | 0 | 0 | 0 | For |
| Invesco | 828,278 | 133,387 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 908,741 | 0 | 0 | 0 | For |
| Jackson National | 800,858 | 0 | 0 | 0 | For |
| Nuveen | 790,147 | 0 | 0 | 0 | For |
| Northern Trust | 761,118 | 0 | 0 | 0 | For |
| New York Life | 734,703 | 0 | 0 | 0 | For |
Showing the 25 largest of 582 asset managers. See all 582 in the interactive database.
Meeting held 2025-05-08.
Combines 9 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
ALNYLAM PHARMACEUTICALS INC.’s own tally for this item (“Proposal 3: The Company's stockholders approved the Company's Second Amended and Restated 2018 Stock Incentive Plan.”): 114,044,496 for, 4,590,661 against, per its Form 8-K filed 2025-05-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 130,311,000 outstanding shares: 88% for, 4% against (91% of the company cast a for/against vote).
The 143 asset managers below cast 98% of the shares they voted on this item FOR (74,036,936 for, 1,363,521 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 17,729,763 | 0 | 0 | 0 | For |
| Vanguard | 15,802,196 | 0 | 0 | 0 | For |
| Fidelity | 13,243,154 | 0 | 0 | 0 | For |
| T. Rowe Price | 5,284,540 | 0 | 0 | 0 | For |
| BlackRock | 3,917,449 | 0 | 0 | 0 | For |
| Dodge & Cox | 2,572,141 | 0 | 0 | 0 | For |
| AMCAP FUND | 2,401,920 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 1,607,880 | 0 | 0 | 0 | For |
| Orbis Allan Gray Ltd | 1,319,195 | 0 | 0 | 0 | For |
| JPMorgan | 1,269,679 | 0 | 0 | 0 | For |
| American Century | 0 | 968,978 | 0 | 0 | Against |
| INVESTMENT CO OF AMERICA | 908,741 | 0 | 0 | 0 | For |
| Jackson National | 800,858 | 0 | 0 | 0 | For |
| New York Life | 734,703 | 0 | 0 | 0 | For |
| TIAA | 684,000 | 0 | 0 | 0 | For |
| State Street | 614,211 | 11 | 0 | 0 | For |
| Charles Schwab | 531,740 | 0 | 0 | 0 | For |
| Invesco | 403,240 | 0 | 0 | 0 | For |
| Prudential/PGIM | 113,597 | 138,476 | 0 | 0 | Against |
| MassMutual | 219,949 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 198,352 | 0 | 0 | 0 | For |
| Federated Hermes | 192,849 | 0 | 0 | 0 | For |
| CARILLON SERIES TRUST | 190,489 | 0 | 0 | 0 | For |
| Equitable | 188,390 | 0 | 0 | 0 | For |
| First Trust | 179,798 | 0 | 0 | 0 | For |
Showing the 25 largest of 143 asset managers. See all 143 in the interactive database.
Meeting held 2025-05-08.
Combines 9 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
ALNYLAM PHARMACEUTICALS INC.’s own tally for this item (“Proposal 5: The Company's stockholders ratified the appointment by the Company's Board of Directors of PricewaterhouseCoopers LLP as the Company's independent auditors for the fiscal year ending December 31, 2025.”): 117,032,947 for, 6,405,215 against, per its Form 8-K filed 2025-05-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 130,311,000 outstanding shares: 90% for, 5% against (95% of the company cast a for/against vote).
The 132 asset managers below cast 99% of the shares they voted on this item FOR (73,072,862 for, 986,391 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 17,729,763 | 0 | 0 | 0 | For |
| Vanguard | 15,037,144 | 765,052 | 0 | 0 | For |
| Fidelity | 13,243,154 | 0 | 0 | 0 | For |
| T. Rowe Price | 5,284,540 | 0 | 0 | 0 | For |
| BlackRock | 3,917,449 | 0 | 0 | 0 | For |
| Dodge & Cox | 2,572,141 | 0 | 0 | 0 | For |
| AMCAP FUND | 2,401,920 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 1,607,880 | 0 | 0 | 0 | For |
| JPMorgan | 1,269,679 | 0 | 0 | 0 | For |
| American Century | 968,978 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 908,741 | 0 | 0 | 0 | For |
| Jackson National | 800,858 | 0 | 0 | 0 | For |
| New York Life | 734,703 | 0 | 0 | 0 | For |
| TIAA | 684,000 | 0 | 0 | 0 | For |
| State Street | 614,200 | 22 | 0 | 0 | For |
| Charles Schwab | 531,740 | 0 | 0 | 0 | For |
| Invesco | 403,240 | 0 | 0 | 0 | For |
| Prudential/PGIM | 252,073 | 0 | 0 | 0 | For |
| MassMutual | 219,949 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 198,352 | 0 | 0 | 0 | For |
| Federated Hermes | 192,849 | 0 | 0 | 0 | For |
| CARILLON SERIES TRUST | 190,489 | 0 | 0 | 0 | For |
| Equitable | 188,390 | 0 | 0 | 0 | For |
| First Trust | 179,798 | 0 | 0 | 0 | For |
| Victory Capital | 176,464 | 0 | 0 | 0 | For |
Showing the 25 largest of 132 asset managers. See all 132 in the interactive database.
Meeting held 2025-05-08.
Combines 7 wordings of this item as funds reported it.
88% Majority: yes · of votes cast
ALNYLAM PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Amy W. Schulman”): 103,753,055 for, 14,370,696 against, per its Form 8-K filed 2025-05-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 130,311,000 outstanding shares: 80% for, 11% against (91% of the company cast a for/against vote).
The 129 asset managers below cast 90% of the shares they voted on this item FOR (66,522,192 for, 7,187,268 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 17,729,763 | 0 | 0 | 0 | For |
| Vanguard | 15,802,195 | 1 | 0 | 0 | For |
| Fidelity | 13,243,154 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 5,284,540 | 0 | 0 | Against |
| BlackRock | 3,917,449 | 0 | 0 | 0 | For |
| Dodge & Cox | 2,572,141 | 0 | 0 | 0 | For |
| AMCAP FUND | 2,401,920 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 1,607,880 | 0 | 0 | 0 | For |
| JPMorgan | 1,269,679 | 0 | 0 | 0 | For |
| American Century | 968,978 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 908,741 | 0 | 0 | 0 | For |
| Jackson National | 368,014 | 432,844 | 0 | 0 | Against |
| New York Life | 734,703 | 0 | 0 | 0 | For |
| TIAA | 684,000 | 0 | 0 | 0 | For |
| State Street | 1,098 | 613,124 | 0 | 0 | Against |
| Charles Schwab | 531,740 | 0 | 0 | 0 | For |
| Invesco | 0 | 58,830 | 344,410 | 0 | Abstain |
| Prudential/PGIM | 252,073 | 0 | 0 | 0 | For |
| MassMutual | 26,477 | 193,472 | 0 | 0 | Against |
| FRANKLIN STRATEGIC SERIES | 198,352 | 0 | 0 | 0 | For |
| Federated Hermes | 192,849 | 0 | 0 | 0 | For |
| CARILLON SERIES TRUST | 190,489 | 0 | 0 | 0 | For |
| Equitable | 141,256 | 47,134 | 0 | 0 | For |
| First Trust | 179,798 | 0 | 0 | 0 | For |
| Victory Capital | 176,464 | 0 | 0 | 0 | For |
Showing the 25 largest of 129 asset managers. See all 129 in the interactive database.
Meeting held 2025-05-08.
Combines 7 wordings of this item as funds reported it.
91% Majority: yes · of votes cast
ALNYLAM PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Carolyn R. Bertozzi, Ph.D.”): 108,200,098 for, 10,440,708 against, per its Form 8-K filed 2025-05-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 130,311,000 outstanding shares: 83% for, 8% against (91% of the company cast a for/against vote).
The 129 asset managers below cast 91% of the shares they voted on this item FOR (67,572,024 for, 6,487,177 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 17,729,763 | 0 | 0 | 0 | For |
| Vanguard | 15,802,195 | 1 | 0 | 0 | For |
| Fidelity | 13,243,154 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 5,284,540 | 0 | 0 | Against |
| BlackRock | 3,917,449 | 0 | 0 | 0 | For |
| Dodge & Cox | 2,572,141 | 0 | 0 | 0 | For |
| AMCAP FUND | 2,401,920 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 1,607,880 | 0 | 0 | 0 | For |
| JPMorgan | 1,269,679 | 0 | 0 | 0 | For |
| American Century | 968,978 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 908,741 | 0 | 0 | 0 | For |
| Jackson National | 368,014 | 432,844 | 0 | 0 | Against |
| New York Life | 734,703 | 0 | 0 | 0 | For |
| TIAA | 684,000 | 0 | 0 | 0 | For |
| State Street | 614,222 | 0 | 0 | 0 | For |
| Charles Schwab | 531,740 | 0 | 0 | 0 | For |
| Invesco | 403,240 | 0 | 0 | 0 | For |
| Prudential/PGIM | 252,073 | 0 | 0 | 0 | For |
| MassMutual | 26,477 | 193,472 | 0 | 0 | Against |
| FRANKLIN STRATEGIC SERIES | 198,352 | 0 | 0 | 0 | For |
| Federated Hermes | 192,849 | 0 | 0 | 0 | For |
| CARILLON SERIES TRUST | 190,489 | 0 | 0 | 0 | For |
| Equitable | 141,256 | 47,134 | 0 | 0 | For |
| First Trust | 179,798 | 0 | 0 | 0 | For |
| Victory Capital | 176,464 | 0 | 0 | 0 | For |
Showing the 25 largest of 129 asset managers. See all 129 in the interactive database.
Meeting held 2025-05-08.
Combines 7 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
ALNYLAM PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Colleen F. Reitan”): 111,919,864 for, 6,734,585 against, per its Form 8-K filed 2025-05-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 130,311,000 outstanding shares: 86% for, 5% against (91% of the company cast a for/against vote).
The 129 asset managers below cast 96% of the shares they voted on this item FOR (71,237,627 for, 2,821,574 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 17,729,763 | 0 | 0 | 0 | For |
| Vanguard | 15,802,195 | 1 | 0 | 0 | For |
| Fidelity | 13,243,154 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,620,560 | 2,663,980 | 0 | 0 | Against |
| BlackRock | 3,917,449 | 0 | 0 | 0 | For |
| Dodge & Cox | 2,572,141 | 0 | 0 | 0 | For |
| AMCAP FUND | 2,401,920 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 1,607,880 | 0 | 0 | 0 | For |
| JPMorgan | 1,269,679 | 0 | 0 | 0 | For |
| American Century | 968,978 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 908,741 | 0 | 0 | 0 | For |
| Jackson National | 800,858 | 0 | 0 | 0 | For |
| New York Life | 734,703 | 0 | 0 | 0 | For |
| TIAA | 684,000 | 0 | 0 | 0 | For |
| State Street | 614,222 | 0 | 0 | 0 | For |
| Charles Schwab | 531,740 | 0 | 0 | 0 | For |
| Invesco | 403,240 | 0 | 0 | 0 | For |
| Prudential/PGIM | 252,073 | 0 | 0 | 0 | For |
| MassMutual | 215,509 | 4,440 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 198,352 | 0 | 0 | 0 | For |
| Federated Hermes | 192,849 | 0 | 0 | 0 | For |
| CARILLON SERIES TRUST | 190,489 | 0 | 0 | 0 | For |
| Equitable | 141,256 | 47,134 | 0 | 0 | For |
| First Trust | 179,798 | 0 | 0 | 0 | For |
| Victory Capital | 176,464 | 0 | 0 | 0 | For |
Showing the 25 largest of 129 asset managers. See all 129 in the interactive database.
Meeting held 2025-05-08.
Combines 7 wordings of this item as funds reported it.
91% Majority: yes · of votes cast
ALNYLAM PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Margaret A. Hamburg, M.D.”): 108,041,420 for, 10,601,230 against, per its Form 8-K filed 2025-05-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 130,311,000 outstanding shares: 83% for, 8% against (91% of the company cast a for/against vote).
The 129 asset managers below cast 91% of the shares they voted on this item FOR (67,572,247 for, 6,486,954 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 17,729,763 | 0 | 0 | 0 | For |
| Vanguard | 15,802,195 | 1 | 0 | 0 | For |
| Fidelity | 13,243,154 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 5,284,540 | 0 | 0 | Against |
| BlackRock | 3,917,449 | 0 | 0 | 0 | For |
| Dodge & Cox | 2,572,141 | 0 | 0 | 0 | For |
| AMCAP FUND | 2,401,920 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 1,607,880 | 0 | 0 | 0 | For |
| JPMorgan | 1,269,679 | 0 | 0 | 0 | For |
| American Century | 968,978 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 908,741 | 0 | 0 | 0 | For |
| Jackson National | 368,014 | 432,844 | 0 | 0 | Against |
| New York Life | 734,703 | 0 | 0 | 0 | For |
| TIAA | 684,000 | 0 | 0 | 0 | For |
| State Street | 614,222 | 0 | 0 | 0 | For |
| Charles Schwab | 531,740 | 0 | 0 | 0 | For |
| Invesco | 403,240 | 0 | 0 | 0 | For |
| Prudential/PGIM | 252,073 | 0 | 0 | 0 | For |
| MassMutual | 26,477 | 193,472 | 0 | 0 | Against |
| FRANKLIN STRATEGIC SERIES | 198,352 | 0 | 0 | 0 | For |
| Federated Hermes | 192,849 | 0 | 0 | 0 | For |
| CARILLON SERIES TRUST | 190,489 | 0 | 0 | 0 | For |
| Equitable | 141,256 | 47,134 | 0 | 0 | For |
| First Trust | 179,798 | 0 | 0 | 0 | For |
| Victory Capital | 176,464 | 0 | 0 | 0 | For |
Showing the 25 largest of 129 asset managers. See all 129 in the interactive database.
Meeting held 2025-05-08.
Combines 3 wordings of this item as funds reported it.
97% fund support · no official result
The 126 asset managers below cast 97% of the shares they voted on this item FOR (71,425,006 for, 2,566,196 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 17,729,763 | 0 | 0 | 0 | For |
| Vanguard | 15,757,815 | 44,381 | 0 | 0 | For |
| Fidelity | 13,243,154 | 0 | 0 | 0 | For |
| T. Rowe Price | 5,284,540 | 0 | 0 | 0 | For |
| BlackRock | 3,917,449 | 0 | 0 | 0 | For |
| Dodge & Cox | 2,572,141 | 0 | 0 | 0 | For |
| AMCAP FUND | 2,401,920 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 1,607,880 | 0 | 0 | 0 | For |
| JPMorgan | 0 | 1,269,679 | 0 | 0 | Against |
| American Century | 968,978 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 908,741 | 0 | 0 | 0 | For |
| Jackson National | 520,660 | 280,198 | 0 | 0 | For |
| New York Life | 734,703 | 0 | 0 | 0 | For |
| TIAA | 684,000 | 0 | 0 | 0 | For |
| State Street | 614,172 | 50 | 0 | 0 | For |
| Charles Schwab | 531,740 | 0 | 0 | 0 | For |
| Invesco | 403,240 | 0 | 0 | 0 | For |
| Prudential/PGIM | 86,556 | 165,517 | 0 | 0 | Against |
| MassMutual | 193,472 | 26,477 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 198,352 | 0 | 0 | 0 | For |
| Federated Hermes | 0 | 192,849 | 0 | 0 | Against |
| CARILLON SERIES TRUST | 190,489 | 0 | 0 | 0 | For |
| Equitable | 67,083 | 121,307 | 0 | 0 | Against |
| First Trust | 179,798 | 0 | 0 | 0 | For |
| Victory Capital | 176,464 | 0 | 0 | 0 | For |
Showing the 25 largest of 126 asset managers. See all 126 in the interactive database.
Meeting held 2025-05-08.
72% fund support · no official result
The 3 asset managers below cast 72% of the shares they voted on this item FOR (28,667 for, 11,330 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Erste Asset Management GmbH | 26,810 | 0 | 0 | 0 | For |
| HC CAPITAL TRUST | 0 | 11,330 | 0 | 0 | Against |
| GuideStone | 1,857 | 0 | 0 | 0 | For |
Meeting held 2025-05-08.
94% fund support · no official result
The 2 asset managers below cast 94% of the shares they voted on this item FOR (46 for, 3 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Simplify Exchange Traded Funds | 46 | 0 | 0 | 0 | For |
| VOISARD ASSET MANAGEMENT GROUP, INC. | 0 | 3 | 0 | 0 | Against |
Meeting held 2025-05-08.
All nominees (reported as one line). These filers reported the election of directors as a single line covering every nominee. It is not attributed to any one director, and no share total is shown for it.
100% fund support · no official result
The 2 asset managers below cast 100% of the shares they voted on this item FOR.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Simplify Exchange Traded Funds | 46 | 0 | 0 | 0 | For |
| VOISARD ASSET MANAGEMENT GROUP, INC. | 3 | 0 | 0 | 0 | For |
Meeting held 2025-05-08.
0% fund support · no official result
The 2 asset managers below cast 0% of the shares they voted on this item FOR (0 for, 28,002 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Cardano Risk Management B.V. | 0 | 27,773 | 0 | 0 | Against |
| Virtus | 0 | 229 | 0 | 0 | Against |
Meeting held 2024-05-16 (outside the 2024-2025 season's 1 July to 30 June window; reported in this season's filings).
Combines 2 wordings of this item as funds reported it.
100% fund support · no official result
The 2 asset managers below cast 100% of the shares they voted on this item FOR (102 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| COLDSTREAM CAPITAL MANAGEMENT INC | 102 | 0 | 0 | 0 | For |
| Echo45 Advisors LLC | 0 | 0 | 0 | 0 | -- |
Ranked by the number of ALNYLAM PHARMACEUTICALS INC. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 130,311,000 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Capital Group | 26.54% |
| 2 | Fidelity | 20.97% |
| 3 | Vanguard | 12.53% |
| 4 | T. Rowe Price | 10.15% |
| 5 | BlackRock | 6.55% |
| 6 | Capital Research Global Investors | 5.46% |
| 7 | Dodge & Cox | 4.40% |
| 8 | State Street | 2.75% |
| 9 | JPMorgan | 2.50% |
| 10 | Wellington | 2.26% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| FMR (Fidelity) | 11.75% | 13F |
| Capital World Investors | 8.38% | 13G |
| BlackRock | 7.34% | 13F |
| Capital Research Global Investors | 7.27% | 13G |
| T. Rowe Price | 2.69% | 13F |
| State Street | 2.58% | 13F |
| Wellington Management | 2.00% | 13F |
| Norges Bank | 1.76% | 13F |
| JPMorgan Chase | 1.70% | 13F |
| Invesco | 0.70% | 13F |
Percentages above are of 130,311,000 shares outstanding, as reported by ALNYLAM PHARMACEUTICALS INC. on its Form 10-Q dated 2025-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from ALNYLAM PHARMACEUTICALS INC.’s 10-Q dated 2025-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At ALNYLAM PHARMACEUTICALS INC.'s shareholder meeting held 2025-05-08, in the 2024-2025 proxy season, 586 asset managers reported how they voted in their SEC Form N-PX filings, covering 5,783 separate fund positions. Their filings are grouped here into 13 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve, in a non-binding advisory vote, the compensation of Alnylam's named executive… — FOR was 94% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: ALNYLAM PHARMACEUTICALS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2025-05-13.
ALNYLAM PHARMACEUTICALS INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.